The global critical illness insurance market size is calculated at USD 445.49 billion in 2025, and is predicted to hit around USD 854.11 billion by 2034, poised to grow at a CAGR of 7.50% between 2025 and 2034. The North America critical illness insurance market size accounted at USD 149.19 billion in 2024 and is anticipated to grow at the fastest CAGR of 7.55% during the forecast year. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Critical Illness Insurance Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Critical Illness Insurance Market, by Premium Type
8.1.1 Monthly
8.1.1.1. Market Revenue and Forecast
8.1.2. Quarterly
8.1.2.1. Market Revenue and Forecast
8.1.3. Half Yearly
8.1.3.1. Market Revenue and Forecast
8.1.4. Yearly
8.1.4.1. Market Revenue and Forecast
9.1. Critical Illness Insurance Market, by Diseases
9.1.1. Cancer
9.1.1.1. Market Revenue and Forecast
9.1.2. Heart Attack
9.1.2.1. Market Revenue and Forecast
9.1.3. Stroke
9.1.3.1. Market Revenue and Forecast
9.1.4. Major Organ Transplant
9.1.4.1. Market Revenue and Forecast
9.1.5. Others
9.1.5.1. Market Revenue and Forecast
10.1. Critical Illness Insurance Market, by Type
10.1.1. Individual Insurance
10.1.1.1. Market Revenue and Forecast
10.1.2. Family Insurance
10.1.2.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Premium Type
11.1.2. Market Revenue and Forecast, by Diseases
11.1.3. Market Revenue and Forecast, by Type
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Premium Type
11.1.4.2. Market Revenue and Forecast, by Diseases
11.1.4.3. Market Revenue and Forecast, by Type
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Premium Type
11.1.5.2. Market Revenue and Forecast, by Diseases
11.1.5.3. Market Revenue and Forecast, by Type
11.2. Europe
11.2.1. Market Revenue and Forecast, by Premium Type
11.2.2. Market Revenue and Forecast, by Diseases
11.2.3. Market Revenue and Forecast, by Type
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Premium Type
11.2.4.2. Market Revenue and Forecast, by Diseases
11.2.4.3. Market Revenue and Forecast, by Type
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Premium Type
11.2.5.2. Market Revenue and Forecast, by Diseases
11.2.5.3. Market Revenue and Forecast, by Type
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Premium Type
11.2.6.2. Market Revenue and Forecast, by Diseases
11.2.6.3. Market Revenue and Forecast, by Type
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Premium Type
11.2.7.2. Market Revenue and Forecast, by Diseases
11.2.7.3. Market Revenue and Forecast, by Type
11.3. APAC
11.3.1. Market Revenue and Forecast, by Premium Type
11.3.2. Market Revenue and Forecast, by Diseases
11.3.3. Market Revenue and Forecast, by Type
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Premium Type
11.3.4.2. Market Revenue and Forecast, by Diseases
11.3.4.3. Market Revenue and Forecast, by Type
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Premium Type
11.3.5.2. Market Revenue and Forecast, by Diseases
11.3.5.3. Market Revenue and Forecast, by Type
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Premium Type
11.3.6.2. Market Revenue and Forecast, by Diseases
11.3.6.3. Market Revenue and Forecast, by Type
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Premium Type
11.3.7.2. Market Revenue and Forecast, by Diseases
11.3.7.3. Market Revenue and Forecast, by Type
11.4. MEA
11.4.1. Market Revenue and Forecast, by Premium Type
11.4.2. Market Revenue and Forecast, by Diseases
11.4.3. Market Revenue and Forecast, by Type
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Premium Type
11.4.4.2. Market Revenue and Forecast, by Diseases
11.4.4.3. Market Revenue and Forecast, by Type
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Premium Type
11.4.5.2. Market Revenue and Forecast, by Diseases
11.4.5.3. Market Revenue and Forecast, by Type
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Premium Type
11.4.6.2. Market Revenue and Forecast, by Diseases
11.4.6.3. Market Revenue and Forecast, by Type
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Premium Type
11.4.7.2. Market Revenue and Forecast, by Diseases
11.4.7.3. Market Revenue and Forecast, by Type
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Premium Type
11.5.2. Market Revenue and Forecast, by Diseases
11.5.3. Market Revenue and Forecast, by Type
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Premium Type
11.5.4.2. Market Revenue and Forecast, by Diseases
11.5.4.3. Market Revenue and Forecast, by Type
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Premium Type
11.5.5.2. Market Revenue and Forecast, by Diseases
11.5.5.3. Market Revenue and Forecast, by Type
12.1. AIA Group Limited
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Manulife Financial Corporation
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Prudential Financial, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Ping An Insurance (Group) Company of China, Ltd.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. China Life Insurance Company Limited
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Allianz SE
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Zurich Insurance Group
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Aviva plc
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Bupa
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. MetLife, Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description